GINC Patents
← Capabilities
Strategic Infrastructure

Medical Supply & Stockpiles

Medical supply and stockpiles covers the logistics of health rather than its delivery, including blood and plasma collection and fractionation, national medical and vaccine stockpiles, cold chain for biologics, pharmaceutical distribution centres and central medical stores. One of the capabilities of Social Infrastructure.

International families
5,7652015 to 2024
Leading country
United States2.7× the next
All families
15khome filings included
Over five years
Falling2020 to 2024 against the five before

Year by year

Patent families by country of origin and the year of the earliest filing, 2000 to 2025; 2025 is a part year, still filling in. International families are those for which protection was sought beyond one country.

Volume

International patent families in the capability, by the year of the earliest filing.

Source: Global Institute for National Capability (GINC), 2026. Underlying patents from 107 patent offices, IFI CLAIMS and Google

Share by country

Each country's share of the year's international families, in per cent: the capability's five largest countries of origin, 2015 to 2024, and the rest of the world.

Source: Global Institute for National Capability (GINC), 2026. Underlying patents from 107 patent offices, IFI CLAIMS and Google

Country leaderboard

International patent families, 2015 to 2024, by country of origin. Growth compares the latest five full years with the five before.

Ten largest

United States

Japan

Germany

China

France

South Korea

Switzerland

United Kingdom

Italy

Canada

2,199

825

501

410

236

232

185

137

123

98

2000 to 2025
1United States2,19938.1%0.9×
2,816
2Japan82514.3%0.5×
1,443
3Germany5018.7%0.8×
570
4China4107.1%1.4×
6,830
5France2364.1%0.5×
268
6South Korea2324.0%0.9×
736
7Switzerland1853.2%0.9×
192
8United Kingdom1372.4%0.9×
157
9Italy1232.1%0.6×
155
10Canada981.7%1.5×
114
11Israel801.4%0.6×
87
12Australia651.1%1.2×
75
13Spain621.1%0.5×
75
14Taiwan591.0%1.0×
95
15India571.0%0.8×
64
16Sweden561.0%0.6×
60
17Belgium500.9%0.6×
53
18Ireland450.8%1.0×
50
19Netherlands390.7%0.9×
45
20Denmark310.5%1.1×
32
21Türkiye290.5%1.4×
34
22Austria260.5%1.2×
29
23Brazil200.3%0.7×
62
24Poland170.3%1.8×
34
25Russia160.3%0.5×
235
26Norway140.2%0.6×
15
27Portugal140.2%0.8×
15
28Finland130.2%1.6×
13
29Singapore130.2%1.2×
13
30Luxembourg90.2%0.8×
9
31Czechia60.1%0.5×
13
32New Zealand50.1%1.5×
6
33South Africa50.1%0.3×
6
34Mexico50.1%0.7×
8
35Saudi Arabia40.1%1.0×
5
36Hungary40.1%0.3×
5
37Hong Kong30.1%2.0×
3
38Liechtenstein30.1%0.5×
4
39Cayman Islands10.0%0.0×
1
40Malaysia10.0%–
2

Applicants

The largest applicants by international patent families, 2015 to 2024: across the world, then within each of the five countries with the most families in Medical Supply & Stockpiles. Names are as held in the source and are not consolidated across subsidiaries.

Global

5,765 international families

TERUMO CORP · Japan

FENWAL INC · United States

SCHOTT AG · Germany

FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH · Germany

CORNING INC · United States

BAXTER INT · United States

146

128

59

46

42

40

United States

2,199 international families

FENWAL INC

CORNING INC

AMGEN INC

BAXTER INT

TERUMO BCT INC

BECTON DICKINSON CO

128

42

37

33

32

31

Japan

825 international families

TERUMO CORP

SCREEN HOLDINGS CO LTD

FUJIFILM CORP

NIPRO CORP

JMS CO LTD

SANTEN PHARMACEUTICAL CO LTD

146

33

27

24

20

20

Germany

501 international families

SCHOTT AG

FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH

FRESENIUS KABI DEUTSCHLAND GMBH

BRAUN MELSUNGEN AG

SCHOTT PHARMA AG & CO KGAA

FRAUNHOFER GES FORSCHUNG

56

46

35

30

29

14

China

410 international families

SHANGHAI ORIGINCELL BIOLOGICAL CRYO EQUIPMENT CO LTD

SHEN ZHEN BIOROCKS BIOTECHNOLOGY COMPANY LTD

BOE TECHNOLOGY GROUP CO LTD

HUNAN CHINA SUN PHARMACEUTICAL MACHINERY CO LTD

HUNAN CHINASUN PHARMACEUTICAL MACHINERY CO LTD

UNIV ZHEJIANG

17

11

9

7

7

7

France

236 international families

MACO PHARMA SA

INST NAT SANTE RECH MED

SARTORIUS STEDIM FMT SAS

BECTON DICKINSON FRANCE

CENTRE NAT RECH SCIENT

LAB FRANCAIS DU FRACTIONNEMENT

21

17

16

12

12

12

Similar capabilities

The nine capabilities that share the most international patent families with Medical Supply & Stockpiles, 2015 to 2024: the families counted in both as a share of those counted in either. Each card shows its five largest countries.

Critical Technology

Biomanufacturing

2.1% shared · 1,604 families in both

United States

China

Japan

South Korea

Germany

25,142

10,048

9,595

4,747

3,497

Production & Innovation

Agrifood & Primary Production

1.5% shared · 1,950 families in both

United States

Japan

China

Germany

South Korea

28,708

17,669

15,613

10,229

9,737

Critical Technology

Advanced Therapeutics, Vaccines & Medical Countermeasures

1.3% shared · 1,051 families in both

United States

China

Japan

South Korea

Germany

35,382

11,223

4,471

4,072

2,767

Human Capital

Knowledge Production

1.3% shared · 497 families in both

United States

Japan

Germany

China

South Korea

9,688

6,387

4,131

2,870

1,604

Human Capital

Service Delivery & Coverage

0.9% shared · 2,309 families in both

United States

Japan

China

South Korea

Germany

84,023

38,520

26,886

18,896

17,937

Human Capital

Physical Health & Longevity

0.9% shared · 1,820 families in both

United States

China

South Korea

Japan

Germany

77,497

32,383

14,190

14,101

7,671

Strategic Infrastructure

Public Health & Laboratories

0.6% shared · 164 families in both

United States

Japan

China

Germany

South Korea

7,163

3,632

2,667

1,475

1,202

Strategic Infrastructure

Livestock & Veterinary

0.5% shared · 71 families in both

United States

China

Japan

Germany

South Korea

1,532

997

648

576

537

Human Capital

Child Health & Nutrition

0.5% shared · 44 families in both

United States

Netherlands

Switzerland

China

South Korea

640

387

380

283

184

Crosswalk

How Medical Supply & Stockpiles is matched to the patent classifications. The entries below were chosen for it; each stands for itself and everything beneath it in the scheme, 49 Cooperative entries in all. A patent family counts when any of its codes, in either scheme and at any office, falls under one of them. Codes since retired are placed under the entries that replaced them.

EntryTitle in the schemeWhy it is chosenCPC codesIPC codesDocuments
A61M1/02Blood transfusion apparatusBlood transfusion and blood bank apparatus20129,262
A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containersContainers for collecting and storing blood and plasma7473,688
A61K35/16Blood plasma; Blood serumBlood plasma and serum products1116,011
C07K16/06Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serumImmunoglobulins obtained from serum2118,548
A01N1/10Preservation of living partsPreservation of blood, organs and other living parts191979,819

CPC and IPC codes are the codes in use on patent documents, at any office, that fall under the entry. Documents is the larger of the two schemes' counts of documents carrying one of them. An entry with no IPC codes can be told apart only in the Cooperative scheme.

The Cooperative codes in use that count towards Medical Supply & Stockpiles: 49 codes on 189,626 documents. The full crosswalk is in the cpc-to-capability.csv download.

CodeTitleUnder entryHow placedDocuments
A61J1/10Bag-type containersA61J1/05In the scheme23,516
C07K16/065Purification, fragmentationC07K16/06In the scheme13,426
A01N1/10Preservation of living partsA01N1/10In the scheme12,726
A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containersA61J1/05In the scheme11,588
A01N1/126Physiologically active agents, e.g. antioxidants or nutrientsA01N1/10In the scheme11,409
A61K35/16Blood plasma; Blood serumA61K35/16In the scheme10,616
A01N1/125Freeze protecting agents, e.g. cryoprotectants or osmolarity regulatorsA01N1/10In the scheme10,412
A01N1/162Temperature processes, e.g. following predefined temperature changes over timeA01N1/10In the scheme6,466
A01N1/122Preservation or perfusion mediaA01N1/10In the scheme5,567
A61J1/065Rigid ampoules, e.g. glass ampoulesA61J1/05In the scheme5,300
A61M1/0209Multiple bag systems for separating or storing blood componentsA61M1/02In the scheme5,215
C07K16/06Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serumC07K16/06In the scheme5,122
A01N1/143Apparatus for organ perfusionA01N1/10In the scheme4,489
A01N1/146Non-refrigerated containers specially adapted for transporting or storing living parts whilst preservingA01N1/10In the scheme4,244
A61J1/06Ampoules or carpulesA61J1/05In the scheme3,761
A61M1/0281Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawingA61M1/02In the scheme3,617
A61M1/0218Multiple bag systems for separating or storing blood components with filtersA61M1/02In the scheme3,510
A61J1/067Flexible ampoules, the contents of which are expelled by squeezingA61J1/05In the scheme3,475
A01N1/147Carriers for immersion in cryogenic fluid for slow freezing or vitrificationA01N1/10In the scheme3,472
A61M1/02Blood transfusion apparatusA61M1/02In the scheme3,396
A61M1/0272Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifugingA61M1/02In the scheme3,394
A01N1/142ApparatusA01N1/10In the scheme3,113
A01N1/145Stationary or portable vessels generating cryogenic temperatures, e.g. liquid nitrogen bathsA01N1/10In the scheme2,906
A01N1/144Apparatus for temperature control, e.g. refrigerators or freeze-drying apparatusA01N1/10In the scheme2,850
A61M1/029Separating blood components present in distinct layers in a container, not otherwise provided forA61M1/02In the scheme2,529
A01N1/148Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving with provisions specially adapted for transportingA01N1/10In the scheme2,432
A61J1/062CarpulesA61J1/05In the scheme2,423
A01N1/128Chemically defined matrices for immobilising, holding or storing living parts, e.g. alginate gels; Chemically altering living parts, e.g. by cross-linkingA01N1/10In the scheme2,370
A01N1/124Disinfecting agents, e.g. antimicrobialsA01N1/10In the scheme2,134
A61J1/12Bag-type containers with means for holding samples of contentsA61J1/05In the scheme1,318
A01N1/12Chemical aspects of preservationA01N1/10In the scheme1,291
A61M1/0231Multiple bag systems for separating or storing blood components with gas separating means, e.g. air outlet through microporous membrane or gas bagA61M1/02In the scheme1,237
A01N1/165Pressure processes, e.g. following predefined pressure changes over timeA01N1/10In the scheme1,134
A01N1/16Physical preservation processesA01N1/10In the scheme1,128
A61M1/025Means for agitating or shaking blood containersA61M1/02In the scheme1,078
A61M1/0236Multiple bag systems for separating or storing blood components with sampling means, e.g. sample bag or sampling portA61M1/02In the scheme970
A01N1/168Physical preservation processes using electromagnetic fields or radiation; using acoustic waves or corpuscular radiationA01N1/10In the scheme848
A01N1/14Mechanical aspects of preservation; Apparatus or containers thereforA01N1/10In the scheme828
A61M1/0259Apparatus for treatment of blood or blood constituents not otherwise provided forA61M1/02In the scheme784
A61M1/0222Multiple bag systems for separating or storing blood components with filters and filter bypassA61M1/02In the scheme731
A61M1/0277Frames constraining or supporting bags, e.g. during freezingA61M1/02In the scheme695
A61M1/0227Multiple bag systems for separating or storing blood components with filters and means for securing the filter against damage, e.g. during centrifugationA61M1/02In the scheme555
A61M1/0286Handling a large number of blood product units, e.g. storage cabinets, blood bank administrationA61M1/02In the scheme429
A61M1/024Means for controlling the quantity of transfused blood, e.g. by weighing the container and automatic stopping of the transfusion after reaching a determined amountA61M1/02In the scheme417
A61M1/0245Means for controlling the quantity of transfused blood, e.g. by weighing the container and automatic stopping of the transfusion after reaching a determined amount combined with blood container shaking meansA61M1/02In the scheme210
A61M1/0213Multiple bag systems for separating or storing blood components with isolated sections of the tube used as additive reservoirsA61M1/02In the scheme190
A61M1/0204Blood stirrers, e.g. for defibrinationA61M1/02In the scheme173
A61M1/0254Means for agitating or shaking blood containers with a support plate moving only in one plane, e.g. horizontalA61M1/02In the scheme91
A61M1/0295Separating blood components present in distinct layers in a container, not otherwise provided for whereby the blood container and a solution container are compressed simultaneously by the same meansA61M1/02In the scheme41
Match: Through its tools
The classification names the equipment or technology the capability draws on, not the capability. The count says how much is being invented for it, not how well it is done. Stockpiles and pharmaceutical distribution have no entry; coverage is limited to blood and plasma handling. The crosswalk is a first pass that nobody has reviewed.

Other capabilities in Social Infrastructure